Endometrial cancer is the most common gynecological malignancy. The traditional sonographic screening technique has been the measurement of the endometrial thickness. There is disagreement, however, as to what constitutes a normal sonographic measurement of the endometrium in postmenopausal women. This case study demonstrates the importance of examining the entirety of the endometrium and surrounding myometrium using sensitive transvaginal color/ power Doppler. Color and/or power Doppler in conjunction with the transvaginal examination will increase the sensitivity of diagnosing endometrial pathology.
Endometrial cancer is the most common gynecological malignancy. The median age at diagnosis is the sixth decade, although 20% to 25% of the cases will be diagnosed premenopausally. [1] [2] [3] [4] [5] [6] There is confusion as to what constitutes a normal sonographic endometrial thickness in a postmenopausal woman, even though the subject has been extensively discussed in the ultrasound literature. [5] [6] [7] [8] [9] For example, 3 separate studies in the Year Book of Ultrasound 1992 listed the following results: 1 . Endometrial thickness (double-layer measurement) with or without hormone replacement therapy (HRT) was considered normal if ≤ 8 mm. 5,8 2. No endometrial cancers were found in postmenopausal women with or without HRT, if ≤ 9 mm. 8 3. Endometrial thickness (double layer) for screening purposes with or without HRT is to be considered normal if ≤ 5 mm. [8] [9] [10] This author's institution defines endometrial thickness > 4 mm as an abnormal endometrium (double-layer measurement) for the postmenopausal woman with or without HRT. 6, 11, 12 This case report is to demonstrate the importance of examining the entirety of the endometrium and its surrounding myometrium using transvaginal color/power Doppler techniques in addition to the gray-scale endometrial measurement. It is the author's opinion that transvaginal gray scale combined with color/power Doppler should be the primary method for the noninvasive evaluation of endometrial abnormalities.
Case Report
A woman in her mid-60s, gravida 4, para 3, Ab 1, on continuous combined hormone replacement therapy of Premarin 0.625 mg and Prometrium 100 mg presented with a history of vaginal spotting and brownish discharge on a single occasion.
Transabdominal and transvaginal ultrasound examinations were performed using the Sonoline Sienna (SIEMENS Medical Systems Inc., Issaquah, WA). With the bladder partially distended, a multifrequency curvilinear transducer operated between 4.5 and 2.5 MHz. The transvaginal exam was performed using a multifrequency curvilinear vaginal probe operating between 6.5 to 4. abnormalities. Differential diagnosis at the time of the ultrasound was endometrial polyp, hyperplasia, or adenocarcinoma.
HYSTEROSCOPY D&C
Based on the ultrasound findings, this patient was referred for hysteroscopy and D&C. The hysteroscope is attached to a video camera system for easy viewing. The hysteroscopic findings showed irregular endometrial tissue, consisting of a polypoid vascular mass over the posterior uterine wall, which was resected and sent for pathologic diagnosis (Fig. 6 ). The remainder of the endometrium was somewhat hypotrophic. The endocervical canal was normal. The pathology report indicated the tumor to be a moderately differentiated invasive endometrial adenocarcinoma (Table 1), endometrioid type (Table 1) , International Federation of Gynecology and Obstetrics (FIGO) Grade 2 ( Table 2) . 
TABLE 1. Pathologist's Terminology

Pelvic cell
During surgery, approximately 300 cc of washings normal saline is instilled into the peritoneal cavity to "wash" the pelvic organs. The fluid is then removed and sent to cytology to determine presence of malignant cells. The purpose is for cancer staging. Endometrioid type Cells that microscopically resemble endometrial tissue. 20 Endometrial cells can appear in other organs such as ovaries. 14 
Endometrial
Malignant neoplastic epithelial cells in a adenocarcinoma gland-like pattern within the endometrium. 1 
Complex
Complex endometrial hyperplasia is endometrial when the epithelial cell resembles hyperplasia proliferative endometrium; with atypia, with atypia the cell resembles well-differentiated adenocarcinoma not proliferative endometrium. 1 Complex endometrial hyperplasia precedes hyperplasia with atypia. Intracytoplasmic A pathology term used to describe mucin mucous secretions into glandular cells. 20
TABLE 2. 1988 International Federation of Gynecology and Obstetrics Pathology Grading for Endometrial Carcinoma
Histopathologic Degree of Differentiation Pathology
Grade 1 5% or less of the tumor shows a solid growth pattern Grade 2 6% to 50 % of the tumor shows a solid growth pattern Grade 3
More than 50% of the tumor shows a solid growth pattern
EXPLORATORY LAPAROTOMY
Based on the tissue pathology, the patient underwent an exploratory laparotomy, pelvic cell washings (Table 1) , total abdominal hysterectomy with bilateral salpingo-oophorectomy, and bilateral pelvic lymph node sampling.
Endometrial cancers are staged based both on the surgical findings during the laparotomy using the FIGO Surgical Stages for Endometrial Cancer (Table 3 ) and the pathologic microscopic evaluation. The purpose of staging a cancer is to determine the extent of the disease and whether radiation and/or chemotherapy are indicated.
The significance of the lymphatic node sampling is to determine if metastatic disease has occurred. The pelvic cell wash is to determine the absence or presence of metastatic cells. The pathologist differentiates a carcinoma, expressed as grade, by architectural growth pattern and nuclear features ( Table 2) .
Findings during the operative procedure were reported as follows:
• The upper abdomen, including the liver, gallbladder, ventral surface of the intestine, the omentum, both kidneys, spleen, paracolic gutters, and node-bearing area, was normal.
• The cecum and appendix were normal.
• The terminal ileum and rectosigmoid colon were normal to palpation.
PATHOLOGIC MICROSCOPIC EVALUATION
The following gross specimens were submitted for pathology: uterus, bilateral fallopian tubes, and ovaries; pelvic cell washings; 5 right pelvic lymph nodes; and 8 left pelvic lymph nodes.
On microscopic evaluation, the tumor involved less than 50% of the myometrium (Figs. 5, 7). Papillary projections were noted within the tumor. The adjacent endometrium revealed complex hyperplasia with atypia (Table 1) . Squamous differentiation was also identified (Fig. 8) . The pathologist subsequently noted several foci of lymphovascular invasion deeper within the myometruim. When lymphovascular invasion is noted, it is important to consider metastatic disease. 1 The forethought and prudent judgment of the surgeon performing a pelvic cell washing and node sampling at the time of the laparotomy saved the patient an additional surgery, which would have been necessary due to the positive lymphovascular invasion. The pelvic cell washings and 13 pelvic lymph nodes showed no evidence of malignant cells.
There was no tumor extension into the endocervix, fallopian tubes, or ovaries. The final surgical staging was FIGO Stage Ib (Table 3) . Diagnosis from pathology was consistent with the previous pathology report obtained during the Table 2) .
The ultrasound images corresponded completely with the surgical findings demonstrating the hyperechoic irregular polypoid projections into the myometrium (Fig. 5 ). Figure 1 clearly demonstrates vascularity originating from the endometrial invasive tumor into the myometrium, while Figure 2 demonstrates low resistant arterial blood flow within the mass indicating an increased arterial blood supply to the tumor mass. Low resistant arterial waveform patterns indicate that vessels are functioning at high capacity, 13 indicative of an active growth pattern in the associated tumor mass. In this patient, the pathology report from the laparotomy was encouraging and the surgical intervention was considered the complete treatment for her cancer. She did not require radiation or chemotherapy and has an excellent prognosis.
Discussion
Endometrioid adenocarcinomas of the uterus represent approximately 80% of all endometrial carcinomas. 1, 4 This cancer usually affects premenopausal and perimenopausal women, is estrogen dependent, and is associated with endometrial hyperplasia, low grade, with less aggressive growth patterns. More aggressive type endometrial adenocarcinomas include the serous, clear-cell, and adenosquamous, representing about 10% of the cases. 2, 4 The more aggressive type commonly affects the postmenopausal woman and is estrogen independent, associated with an atrophic endometrium and a high-grade aggressive growth tumor. 2, 4 There is usually an increased vascular flow within the tumor masses. The most effective course of treatment depends on careful pathological cell grading ( Table 2) . 5 Endometrioid tumors are composed of glands that resemble normal endometrial glands. They have columnar cells with basally oriented nuclei, little or no intracytoplasmic mucin (Table 1) , and smooth intraluminal surfaces (Fig. 7) . 1, 14 As tumors become less differentiated, they contain more solid areas, less glandular formations, and more cytologic atypia. The well-differentiated lesions may be difficult to separate from atypical hyperpla- sia. 1, 5, 14 Criteria that indicate the presence of invasion and are used to diagnose carcinoma are desmoplastic stroma (glands back to back without intervening stroma), extensive papillary pattern, and squamous epithelial differentiation. 1 Approximately 15% to 25% of endometrioid carcinomas have areas of squamous differentiation (Fig. 8 ). 1 Menopause after age 52, nulliparity, obesity, diabetes, previous radiation, and the administration of unopposed estrogen or tamoxifen places women in a higher risk category for this type of cancer. 15 Any vaginal discharge, spotting, or bleeding should alert the patient to seek medical advice, with or without HRT. Treating precancerous endometrial hyperplasia with progestins, a D&C, or hysterectomy can prevent abnormal, precancerous cells from developing into cancer. 3,5 Approximately 10% to 30% of all hyperplasia cases eventually develop into cancer if left untreated. 5, 15 All cases of atypia hyperplasia will evolve to cancer. 1, 5, 6 Early detection is the key to a good prognostic conclusion. 5, 15 
Role of Transvaginal Color/Power Doppler
The normal endometrium should be avascular and hypotrophic in the postmenopausal woman, with or without HRT. 7, 16 The normal endometrial cavity is triangular in shape ( Fig. 9 ), as depicted on gross anatomical evaluation and 3-dimensional ultrasound imaging. Two-dimensional ultrasound depicts cross-sectional planes demonstrating a linear appearance, which is used for the sagittal endometrial measurement (Fig. 10 ). It is, therefore, important for the sonographer to scan both sagittally and coronally throughout the entirety of the uterus, observing any irregularities such as polyps, submucosal leiomyomas, and early endo- Figure 7 demonstrating the squamous cell differentiation. The arrow points to squamous cell differentiation, which is a pathological term to describe the glandular components of the cancer in relation to the epithelial squamous cells. 1 metrial abnormalities. These abnormalities most often will be located in an isolated region of the endometrial cavity.
Abnormalities of the endometrium such as polyps, submucosal lieomyomas, hyperplasia, and carcinomas require a blood supply to evolve. 17 As the ultrasound manufacturers continue to improve the Doppler sensitivities, the significance of detecting vascularization within the endometrium enhances diagnostic confidence. Color Doppler is flow-direction dependent and can miss vessel presence if the pulse repetition frequency is adjusted too high. 18 Since power, energy, or amplitude Doppler is less flow-direction dependent, it is more sensitive to the multidirectional vessels found in polyps, submucosal leiomyomas, hyperplasia, and carcinomas. 7, 18 Polyps tend to be hyperechoic masses with a single artery and vein at the polyp stalk. Submucosal lieomyomas are most commonly hypoechoic and heterogenous in echotexture; however, they can be hypoechoic, isoechoic, or hyperechoic depending on the developmental stage. 7, 17 The vascular flow patterns will typically demonstrate vessels surrounding the myoma with fingerlike vascular projections toward the center. 17 Hyperplasia is generally diffuse, hyperechoic, and may contain complex cystic changes throughout the endometrium. 7 Venous vascularity is prominent. Endometrial cancers can assume some or all of these characteristics, which are detectable using modern ultrasound equipment with sensitive color/power Doppler capabilities.
Conclusion
Early detection is the best prevention from developing invasive endometrial carcinoma. A careful transvaginal ultrasound evaluation of the endometrium using color Doppler (low pulse repetition frequency) and/or power Doppler imaging on the postmenopausal woman will make possible early detection of endometrial abnormalities with or without symptoms. The patient in this case report had a single episode of vaginal spotting. The patient's prognosis would have been less promising had this episode not have been investigated and the ultrasound examination delayed until further symptoms developed.
Color and/or power Doppler in conjunction with the transvaginal exam will increase the sensitivity of diagnosing endometrial pathology. This patient had an endometrial measurement of 5.8 mm, which is often considered within normal limits of postmenopausal women using HRT. However, careful examination of the endometrium and the surrounding myometrium using color Doppler clearly indicated a significant abnormality strongly suggestive of an invasive carcinoma of the endometrium. The chances of survival decrease markedly as endometrial cancer progresses due to delayed evaluation. 1, [3] [4] [5] 7, 19 It is the author's opinion that a postmenopausal woman, with or without HRT, who has any unusual vaginal bleeding or spotting should be evaluated with transvaginal sonography and color/power Doppler. It is the physician's responsibility to determine at what endometrial thickness further evaluation is indicated; however, if each patient is viewed as having a potential cancer, fewer malignancies would go undiagnosed using the techniques already discussed. Transvaginal sonography including color/ power Doppler is the most economical highly sensitive noninvasive examination on the market today for detection of endometrial pathology. [9] [10] [11] 
